Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Review
[키워드] administration
affecting
Analysis
Antibiotic therapy
anticancer
Antiretroviral therapy
Bacterial infections
Cancer
cancer patient
Clinical practice
clinical trial
complex
correlation
COVID-19
described
disease
Evidence
excluded
HBV
HCV
Hepatitis
HIV
Immune checkpoint inhibitors
immune system
Immunotherapy
impairing
implication
Infection
Infectious disease
lung cancer
lung cancer patient
lung cancer patients
management
microbiota
Mortality
Non-small cell lung cancer
outcome
Patient
patient subgroup
patients
patients treated
performed
Prognosis
prognostic
Prospective trial
reported
retrospective
risk of COVID-19
safety profile
suggested
therapy
Thoracic
toxicities
Treatment
trials
viral infection
viral infections
virus
with HIV
[DOI] 10.3390/ijms22010042 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22010042 PMC 바로가기 [Article Type] Review